Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:96-104
Published online before print November 30, 2006, doi: 10.1161/01.RES.0000253904.53601.c9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
100/1/96    most recent
01.RES.0000253904.53601.c9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tocchetti, C. G.
Right arrow Articles by Paolocci, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tocchetti, C. G.
Right arrow Articles by Paolocci, N.
Related Collections
Right arrow Contractile function
Right arrow Biochemistry and metabolism
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Ion channels/membrane transport
(Circulation Research. 2007;100:96.)
© 2007 American Heart Association, Inc.


Cellular Biology

Nitroxyl Improves Cellular Heart Function by Directly Enhancing Cardiac Sarcoplasmic Reticulum Ca2+ Cycling

Carlo G. Tocchetti*, Wang Wang*, Jeffrey P. Froehlich*, Sabine Huke, Miguel A. Aon, Gerald M. Wilson, Giulietta Di Benedetto, Brian O’Rourke, Wei Dong Gao, David A. Wink, John P. Toscano, Manuela Zaccolo, Donald M. Bers, Hector H. Valdivia, Heping Cheng, David A. Kass, Nazareno Paolocci

From the Cardiology Division (C.G.T., M.A.A., B.O’R., D.A.K., N.P.) and Division of Anesthesiology and Critical Care Medicine (W.D.G.), Johns Hopkins Medical Institutions, Baltimore, Md; Cardiovascular Sciences Laboratory (W.W., H.C.), National Institute of Aging, NIH, Baltimore, Md; Department of Biochemistry & Molecular Biology (J.P.F., G.M.W.), University of Maryland, Baltimore; Department of Physiology (S.H., D.M.B.), Loyola University Chicago, Maywood, Ill; Dulbecco Telethon Institute (G.D.B., M.Z.), Venetian Institute of Molecular Medicine, Padua, Italy; Radiation Biology Branch (D.A.W.), National Cancer Institute, NIH, Bethesda, Md; Department of Chemistry (J.P.T.), Johns Hopkins University, Baltimore, Md; Department of Physiology (H.H.V.), University of Wisconsin Medical School, Madison; and Institute of Molecular Medicine (H.C.), Peking University, Beijing, China.

Correspondence to Nazareno Paolocci, MD, PhD, Ross Bldg 835, Cardiology Division, Johns Hopkins Medical Institutions, 720 Rutland Ave, Baltimore, MD 21205. E-mail npaoloc1{at}jhmi.edu

Heart failure remains a leading cause of morbidity and mortality worldwide. Although depressed pump function is common, development of effective therapies to stimulate contraction has proven difficult. This is thought to be attributable to their frequent reliance on cAMP stimulation to increase activator Ca2+. A potential alternative is nitroxyl (HNO), the 1-electron reduction product of nitric oxide (NO) that improves contraction and relaxation in normal and failing hearts in vivo. The mechanism for myocyte effects remains unknown. Here, we show that this activity results from a direct interaction of HNO with the sarcoplasmic reticulum Ca2+ pump and the ryanodine receptor 2, leading to increased Ca2+ uptake and release from the sarcoplasmic reticulum. HNO increases the open probability of isolated ryanodine-sensitive Ca2+-release channels and accelerates Ca2+ reuptake into isolated sarcoplasmic reticulum by stimulating ATP-dependent Ca2+ transport. Contraction improves with no net rise in diastolic calcium. These changes are not induced by NO, are fully reversible by addition of reducing agents (redox sensitive), and independent of both cAMP/protein kinase A and cGMP/protein kinase G signaling. Rather, the data support HNO/thiolate interactions that enhance the activity of intracellular Ca2+ cycling proteins. These findings suggest HNO donors are attractive candidates for the pharmacological treatment of heart failure.


Key Words: nitroxyl • contractility • ryanodine receptor • sarcoplasmic reticulum Ca2+-ATPase • excitation/contraction coupling




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G. Lim, L. Venetucci, D. A. Eisner, and B. Casadei
Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling
Cardiovasc Res, January 15, 2008; 77(2): 256 - 264.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
A. Belevych, Z. Kubalova, D. Terentyev, R. L. Hamlin, C. A. Carnes, and S. Gyorke
Enhanced Ryanodine Receptor-Mediated Calcium Leak Determines Reduced Sarcoplasmic Reticulum Calcium Content in Chronic Canine Heart Failure
Biophys. J., December 1, 2007; 93(11): 4083 - 4092.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. Dai, Y. Tian, C. G. Tocchetti, T. Katori, A. M. Murphy, D. A. Kass, N. Paolocci, and W. D. Gao
Nitroxyl increases force development in rat cardiac muscle
J. Physiol., May 1, 2007; 580(3): 951 - 960.
[Abstract] [Full Text] [PDF]